<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>25817960</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Cabrerizo, J</dc:author>
<dc:author>Satué, M</dc:author>
<dc:author>Rodríguez-Calvo-de-Mora, M</dc:author>
<dc:author>Naveiras, M</dc:author>
<dc:author>Melles, G R J</dc:author>
<dc:author>Dapena, I</dc:author>
<dc:description xml:lang="en">OBJECTIVES To evaluate the clinical outcome of the first 450 consecutive cases after Descemet membrane endothelial keratoplasty (DMEK), as well as the effect of standardization of the technique. MATERIAL AND METHODS Comparison between 3 groups: Group I: (cases 1-125), as the extended learning curve; Group II: (cases 126-250), transition to technique standardization; Group III: (cases 251-450), surgery with standardized technique. Best corrected visual acuity, endothelial cell density, pachymetry and intra- and postoperative complications were evaluated before, and 1, 3 and 6 months after DMEK. RESULTS At 6 months after surgery, 79% of eyes reached a best corrected visual acuity of≥0.8 and 43%≥1.0. Mean preoperative endothelial cell density was 2,530±220 cells/mm2 and 1,613±495 at 6 months after surgery. Mean pachymetry measured 668±92 μm and 526±46 μm pre- and (6 months) postoperatively, respectively. There were no significant differences in best corrected visual acuity, endothelial cell density and pachymetry between the 3 groups (P &gt; .05). Graft detachment presented in 17.3% of the eyes. The detachment rate declined from 24% to 12%, and the rate of secondary surgeries from 9.6% to 3.5%, from group I to III respectively. CONCLUSIONS Visual outcomes and endothelial cell density after DMEK are independent of the technique standardization. However, technique standardization may have contributed to a lower graft detachment rate and a relatively low number of secondary interventions required. As such, DMEK may become the first choice of treatment in corneal endothelial disease.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:subject>Distrofia endotelial de Fuchs</dc:subject>
<dc:subject>Endothelial keratoplasty</dc:subject>
<dc:subject>Descemet membrane endothelial keratoplasty</dc:subject>
<dc:subject>Queratopatía bullosa</dc:subject>
<dc:subject>Bullous keratopathy</dc:subject>
<dc:subject>Learning curve</dc:subject>
<dc:subject>Fuchs endothelial dystrophy</dc:subject>
<dc:subject>Curva de aprendizaje</dc:subject>
<dc:subject>Trasplante endotelial</dc:subject>
<dc:subject>Trasplante endotelial con membrana de Descemet</dc:subject>
<dc:date>2015 Aug </dc:date>
<dc:title xml:lang="en">Standardization of the Descemet membrane endothelial keratoplasty technique: Outcomes of the first 450 consecutive cases.</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
